Loading...
Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
Despite treatment with standard-of-care medications, including currently available biologic therapies, many patients with severe asthma have uncontrolled disease, which is associated with a high risk of hospitalization and high healthcare costs. Biologic therapies approved for severe asthma have ind...
Na minha lista:
| Udgivet i: | Respir Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7560289/ https://ncbi.nlm.nih.gov/pubmed/33059715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-020-01505-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|